Pertussis serodiagnosis in Belgium from 1990 to 2009

Clinical and Vaccine Immunology

Volumn 18, Issue 4, 2011, Pages 588-594

  Vincent, Muriel ^a   Rodeghiero, Caroline ^a   Eylenbosch, Romain ^a   Mans, Yvan ^a   Swalus Steenhouwer, Jeannine ^a   Piérard, Denis ^b   Huygen, Kris ^a   Vanhoof, Raymond ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGGLUTINATION TEST; ARTICLE; BACTERIUM CULTURE; BELGIUM; BORDETELLA PERTUSSIS; CHILD; COMPLEMENT FIXATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGGLUTINATION TESTS; ANTIBODIES, BACTERIAL; BELGIUM; BORDETELLA PERTUSSIS; CHILD; CLINICAL LABORATORY TECHNIQUES; COMPLEMENT FIXATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; INCIDENCE; MALE; SEROLOGIC TESTS; WHOOPING COUGH; YOUNG ADULT;

EID: 79954467377     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00003-11     Document Type: Article

References (25)

1. Cherry, J. D. 1999. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin. Infect. Dis. 28:S107-S111.
2. Cherry, J. D., E. Grimprel, N. Guiso, U. Heininger, and J. Mertsola. 2005. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. 24:S25-S34.
3. Crowcroft, N. S., N. Andrews, C. Rooney, M. Brisson, and E. Miller. 2002. Deaths from pertussis are underestimated in England. Arch. Dis. Child. 86:336-338.
4. Crowcroft, N. S., and R. G. Pebody. 2006. Recent developments in pertussis. Lancet 367:1926-1936.
5. Deeks, S., et al. 1999. Failure of physicians to consider the diagnosis of pertussis in children. Clin. Infect. Dis. 28:840-846.
6. de Greeff, S. C., et al. 2010. Pertussis disease burden in the household: how to protect young infants. Clin. Infect. Dis. 50:1339-1345.
7. Demaria, A., and S. M. Lett. 2010. Vaccinate the village. Clin. Infect. Dis. 50:1346-1348.
8. De Schutter, I., et al. 2003. Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. Clin. Infect. Dis. 36:1391-1396.
9. Forsyth, K. D., et al. 2004. New pertussis vaccination strategies beyond infancy: recommendations by the Global Pertussis Initiative. Clin. Infect. Dis. 39:1802-1809.
10. Guiso, N., et al. 2011. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 30:307-312.
11. He, Q. 1994. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J. Infect. Dis. 170:873-877.
12. Marchant, C. D., et al. 1994. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis and vaccine effectiveness. J. Infect. Dis. 169:1297-1305.
13. Mattoo, S., and J. D. Cherry. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella species. Clin. Microbiol. Rev. 18:326-382.
14. McNabb, S. J., R. A. Jakosky, and P. A. Hall-Baker. 2007. Summary of notifiable diseases - United States, 2005. MMWR Morb. Mortal. Wkly. Rep. 54:1-92.
15. Menzies, S. L., et al. 2009. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin. Vaccine Immunol. 16:1781-1788.
16. Reder, S., M. Riffelmann, C. Becker, and C. H. Wirsing von König. 2008. Measuring immunoglobulin G antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay. Clin. Vaccine Immunol. 15:744-749.
17. Theeten, H., et al. 2009. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium. Acta Paediatr. 98:1307-1312.
18. Tondella, M. L., et al. 2009. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine 27:803-814.
19. van der Zee, A., C. Agterberg, M. Peeters, F. Mooi, and J. Schellekens. 1996. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J. Infect. Dis. 174:89-96.
20. Van Rie, A., A. M. Wendelboe, and J. A. Englund. 2005. Role of maternal pertussis antibodies in infants. Pediatr. Infect. Dis. J. 24:S62-S65.
21. Vellinga, A., A. M. Depoorter, and P. Van Damme. 2002. Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium. Acta Paediatr. 91:599-603. (Pubitemid 34620650)
22. Wendelboe, A. M., et al. 2007. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 26:293-299.
23. Wendelboe, A. M., and A. Van Rie. 2006. Diagnosis of pertussis: a historical review and recent developments. Expert Rev. Mol. Diagn. 6:857-864.
24. Wendelboe, A. M., A. Van Rie, S. Salmaso, and J. A. Englund. 2005. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 24:S58-S61.
25. Xing, D., et al. 2009. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin. Vaccine Immunol. 16:303-311.